| Net income | -358.62M |
| (Gain) loss from discontinued operations | |
| Loss from equity method investments, net of distributions | |
| Deferred income tax expense | -187.23M |
| Depletion, depreciation, amortization and proved property impairment | |
| Exploration dry hole costs | 2K |
| Mark-to-market gain on gas and oil derivatives not designated as hedges | |
| Abandonment and impairment of unproved properties | 23.77M |
| Unrealized derivative gain | |
| Allowance for bad debts | 800K |
| Deferred and stock-based compensation | |
| Amortization of deferred financing costs, loss on extinguishment of debt and other | |
| Loss (gain) on sale of assets | 7.54M |
| Accounts receivable | 31.99M |
| Inventory and other | -776K |
| Accounts payable | -41.27M |
| Accrued liabilities and other | |
| Net cash provided from continuing operations | 202.04M |
| Net cash provided from discontinued operations | |
| Net cash provided from operating activities | |
| Additions to oil and gas properties | -339.45M |
| Additions to field service assets | -1.54M |
| Acreage and proved property purchases | -29.2M |
| Other assets | 0 |
| Proceeds from disposal of assets | |
| Purchase of marketable securities held by the deferred compensation plan | -33.46M |
| Proceeds from the sales of marketable securities held by the deferred compensation plan | 37.9M |
| Net cash used in investing activities from continuing operations | -166.74M |
| Investing activities of discontinued operations | |
| Net cash provided from (used in) investing activities | |
| Borrowing on credit facilities | 1.89B |
| Repayment on credit facilities | -1.05B |
| Dividends paid | -11.65M |
| Issuance of common stock | |
| Issuance of subordinated notes | |
| Repayment of subordinated notes | 0 |
| Debt issuance costs | |
| Change in cash overdrafts | 432K |
| Proceeds from the sales of common stock held by the deferred compensation plan | |
| Net cash (used in) provided from financing activities | |
| Increase in cash and equivalents | 71K |
| Cash and cash equivalents at beginning of period | 471K |
| Cash and cash equivalents at end of period | 542K |